Laboratory informatics based evaluation of methylene tetrahydrofolate reductase C677T genetic test overutilization
暂无分享,去创建一个
[1] T. Ramón Y Cajal,et al. What factors may influence psychological well being at three months and one year post BRCA genetic result disclosure? , 2012, Breast.
[2] Elaine Gray,et al. Clinical guidelines for testing for heritable thrombophilia , 2010, British journal of haematology.
[3] Robert Cook-Deegan,et al. Disclosure of APOE genotype for risk of Alzheimer's disease. , 2009, The New England journal of medicine.
[4] Brian H Shirts,et al. Changing interpretations, stable genes: responsibilities of patients, professionals, and policy makers in the clinical interpretation of complex genetic information , 2008, Genetics in Medicine.
[5] J. Hirsh,et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[6] P. Romundstad,et al. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population – results from the HUNT 2 study , 2008, British journal of haematology.
[7] J. Caprini,et al. Hyperhomocysteinemia and thrombosis: an overview. , 2007, Archives of pathology & laboratory medicine.
[8] F. Rosendaal,et al. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. , 2007, Archives of internal medicine.
[9] B. Dallapiccola,et al. Genetic testing in Italy, year 2004 , 2006, European Journal of Human Genetics.
[10] R. Clarke,et al. Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies , 2005, Journal of thrombosis and haemostasis : JTH.
[11] A. Sturm,et al. Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. , 2005, Circulation.
[12] M. Hessner,et al. Detection of genomic polymorphisms associated with venous thrombosis using the invader biplex assay. , 2004, The Journal of molecular diagnostics : JMD.
[13] S. Vollset,et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide , 2003, Journal of medical genetics.
[14] A. Folsom,et al. Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal investigation of thromboembolism etiology (LITE) , 2003, American journal of hematology.
[15] W. Grody,et al. American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing , 2001, Genetics in Medicine.
[16] Quanhe Yang,et al. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. , 2000, American journal of epidemiology.
[17] M. Margaglione,et al. The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the Prothrombin , 1998, Thrombosis and Haemostasis.
[18] F. Costa,et al. The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis , 1997, Thrombosis and Haemostasis.
[19] J. Yarnell,et al. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. , 1996, QJM : monthly journal of the Association of Physicians.
[20] R. Matthews,et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.